Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
56 /100
HIGH RISK
Score updated Aug 28, 2026

LUCD — Lucid Diagnostics Inc. Dilution Risk Tracker

Track LUCD dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track LUCD — Get alerts when the score changes →

As of August 28, 2026, Lucid Diagnostics Inc. (LUCD) has a DilutionWatch DilutionScore of 56/100, rated HIGH dilution risk. Lucid Diagnostics Inc. has a market capitalization of $196.48M, 203.24M shares outstanding, 103 institutional holders tracked. Stored dilution-related fields include shelf registration capacity of $175.00M, ATM program capacity of $175.00M.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
100
💰 Cash Runway
40
📊 Float Risk
17
⚠️ Warrant Exposure
40
🔄 Convertible Debt
15

Dilution Forecast

Watch
Minor dilution signals detected
model est. 28%
💰 Capital Raise model 38%
• Active shelf registration ($175M, 89% of market cap)
• Active ATM program with $175M remaining capacity
🔄 Reverse Split model est. 30%
• 50-day avg $1.12 approaching $1 threshold
🔔 Track LUCD — Get forecast alerts →

Market Data

Market Cap$196.48M
Shares Outstanding203.24M
Float140.58M
Cash$47.33M
Debt$24.28M
Short InterestN/A

Institutional Holdings

QoQ: ↑ 24.5% shares (2026Q1 vs prior)
103 institutional holders · 40.33M shares
#1 VANGUARD CAPITAL MANAGEMENT LLC 8.31M shares
#2 BlackRock, Inc. 4.64M shares
#3 MASTERS CAPITAL MANAGEMENT LLC 4.00M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest12.13M
Days to Cover8.3
% of Float8.6%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2025-12-31
8-K 8K EVENT 2026-04-23
424B5 ATM 2026-04-23
3 FORM3 2026-04-13
EFFECT EFFECT 2026-03-26
Full SEC filing analysis available with free account

Recent News

No recent news

Factual LUCD Dilution Snapshot

Lucid Diagnostics Inc. (LUCD) has a DilutionScore of 56/100, rated High dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track LUCD Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking LUCD — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Med Devices sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for LUCD
LUCD FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.